TKT and neoplasm: To find out whether the HSV-tk transgene impacts the tumor selectivity of OTS-412, a bioluminescence assay was conducted on day 7, after single-dose IT injection of OTS-412 on day 0 in HCT 116 tumor-bearing mice; the luciferase signal was detected in tumors, but not in other organs (Figure 4A).